E-viri
Recenzirano
-
Reiman, Eric M
Nature (London), 03/2023, Letnik: 615, Številka: 7950Journal Article
Researchers have long sought a treatment for Alzheimer's disease that could target the biological underpinnings of the condition and slow cognitive decline and its disabling consequences in definitive clinical trials. ...it confirms the hypothesis that certain Aß aggregates are involved in the development, treatment and potential prevention of Alzheimer's disease. ...it will help researchers and clinicians to identify those Aß, tau, neuroinflammatory or neurodegenerative biomarker outcome measurements that are reasonably likely to be associated with a treatment's clinical benefit.
